Document is current
Any future updates will be listed below
-
Authors
López-Pereira, Patricia https://orcid.org/0009-0003-8279-6259
Bazarbachi, Ali https://orcid.org/0000-0002-7171-4997
Marçais, Ambroise https://orcid.org/0000-0002-6844-7920
Ngoya, Maud https://orcid.org/0000-0002-7810-6900
Khvedelidze, Irma
Laurence, Arian https://orcid.org/0000-0003-0942-8292
Potter, Victoria
Sicre de Fontbrune, Flore https://orcid.org/0000-0003-2000-1556
Tanase, Alina Daniela https://orcid.org/0000-0003-3075-499X
Cook, Lucy https://orcid.org/0000-0002-8234-5090
Chaganti, Sridhar
Nicholson, Emma https://orcid.org/0000-0002-6439-0795
Serroukh, Yasmina
Clay, Jennifer
Labussière-Wallet, Hélène https://orcid.org/0000-0003-0543-9592
Ciceri, Fabio https://orcid.org/0000-0003-0873-0123
Glass, Bertram
Hermine, Olivier
Sureda Balari, Anna https://orcid.org/0000-0002-1238-6970
- License Information
-
More Information
Article History
Received: 28 September 2025
Revised: 22 November 2025
Accepted: 12 December 2025
First Online: 3 January 2026
Competing interests
: The authors declare no competing interests.
: This retrospective study was conducted according to Good Clinical Practice and following the Declaration of Helsinki. It was approved by the Lymphoma Working Party (LWP) of the EBMT.
: An informed consent was designed, and it was signed, when suitable, by the subjects analyzed in this study.
